Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
November 4, 2021
Consolidated Financial Results
for the Nine Months Ended September 30, 2021
(Under Japanese GAAP)
Company name: | KH Neochem Co., Ltd. | |
Listing: | Tokyo Stock Exchange | |
Securities code: | 4189 | |
URL: | https://www.khneochem.co.jp/en/ | |
Representative: | Michio Takahashi, Representative Director, President & Chief Executive Officer | |
Inquiries: | Masaya Hamamoto, Board Director, Senior Corporate Officer & Chief Financial Officer | |
Telephone: | +81-3-3510-3550 | |
Scheduled date to file quarterly securities report: | November 4, 2021 | |
Scheduled date to commence dividend payments: | - |
Preparation of supplementary material on quarterly financial results:
Holding of quarterly financial results briefing:
(Yen amounts are rounded down to millions, unless otherwise noted.)
1. Consolidated Financial Results for the Nine Months Ended September 30, 2021 (from January 1, 2021 to September 30, 2021)
(1) Consolidated Operating Results (cumulative) | (Percentages indicate year-on-year changes.) | ||||||||||||
Net sales | Operating income | Ordinary income | Net income attributable | ||||||||||
to owners of parent | |||||||||||||
Nine months ended | Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | |||||
September 30, 2021 | 83,778 | 52.5 | 13,998 | 299.4 | 14,352 | 324.1 | 10,077 | 328.3 | |||||
September 30, 2020 | 54,933 | (22.7) | 3,504 | (53.9) | 3,383 | (57.3) | 2,352 | (57.4) | |||||
Note: Comprehensive income For the nine months ended September 30, 2021: | ¥10,187 million [305.0 %] | ||||||||||||
For the nine months ended September 30, 2020: | ¥2,515 million [(55.8)%] | ||||||||||||
Basic earnings | Diluted earnings | ||||||||||||
per share | per share | ||||||||||||
Nine months ended | Yen | Yen | |||||||||||
September 30, 2021 | 271.56 | - | |||||||||||
September 30, 2020 | 63.47 | 63.39 | |||||||||||
(2) Consolidated Financial Position | |||||||||||||
Total assets | Net assets | Equity ratio | |||||||||||
As of | Millions of yen | Millions of yen | % | ||||||||||
September 30, 2021 | 109,345 | 53,737 | 46.8 | ||||||||||
December 31, 2020 | 95,508 | 45,884 | 45.4 | ||||||||||
Reference: Equity As of September 30, 2021: | ¥51,200 million | ||||||||||||
As of December 31, 2020: | ¥43,380 million |
2. Cash Dividends
Annual dividends per share | |||||||
First quarter-end | Second quarter- | Third quarter-end | Fiscal year-end | Total | |||
end | |||||||
Yen | Yen | Yen | Yen | Yen | |||
Fiscal year ended | - | 30.00 | - | 30.00 | 60.00 | ||
December 31, 2020 | |||||||
Fiscal year ending | - | 30.00 | - | ||||
December 31, 2021 | |||||||
Fiscal year ending | |||||||
December 31, 2021 | 45.00 | 75.00 | |||||
(Forecast) | |||||||
Note: Revisions to the forecast of cash dividends most recently announced: Yes |
3. Forecasts of Consolidated Financial Results for the Year Ending December 31, 2021 (from January 1, 2021 to December 31, 2021)
(Percentages indicate changes from the previous corresponding period.)
Net income | Basic | |||||||||
Net sales | Operating income | Ordinary income | attributable to | earnings | ||||||
owners of parent | per share | |||||||||
Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | Yen | ||
Full year | 116,000 | 50.0 | 18,500 | 227.8 | 18,700 | 232.3 | 13,000 | 221.3 | 350.32 |
Note: Revisions to the forecast of consolidated financial results most recently announced: Yes
Please refer to "Notice regarding the revisions of Financial Forecasts and Dividend Forecasts" announced on November 4, 2021.
- Notes
- Changes in significant subsidiaries during the period (changes in specified subsidiaries resulting in the change in scope of consolidation): None
- Adoption of accounting treatment specific to the preparation of quarterly consolidated financial statements: Yes (Calculation of income tax expenses)
- Changes in accounting policies, changes in accounting estimates, and restatement
-
Changes in accounting policies due to revisions to accounting standards and other regulations: None
② Changes in accounting policies due to other reasons: None
③ Changes in accounting estimates: None
④ Restatement: None
-
Changes in accounting policies due to revisions to accounting standards and other regulations: None
- Number of issued shares (common shares)
- Total number of issued shares at the end of the period (including treasury stock)
As of September 30, 2021 | 37,149,400 shares |
As of December 31, 2020 | 37,149,400 shares |
- Number of treasury stock at the end of the period
As of September 30, 2021 | 50,004 shares |
As of December 31, 2020 | 28,379 shares |
(Note) Total number of treasury stock at the end of the period includes the number of the Company's shares held by the Company's Board Benefit Trust (BBT) (September 30, 2021: 49,600 shares, December 31, 2020: 28,000 shares).
- Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year)
Nine months ended September 30, 2021 | 37,110,978 shares |
Nine months ended September 30, 2020 | 37,065,550 shares |
(Note) The number of treasury stock deducted in the calculation of Average number of shares during the period includes the number of the Company's shares held by Board Benefit Trust (BBT) (Nine months ended September 30, 2021: 38,031 shares, Nine months ended September 30, 2020: 19,072 shares).
- Quarterly financial results reports are exempt from quarterly review conducted by certified public accountants or an audit corporation.
-
Proper use of earnings forecasts, and other special matters
Earnings forecasts and other forward-looking statements included in this document are based on the information currently available to the Company and certain assumptions deems reasonable, and the Company makes no commitments regarding their achievability. Actual business results may differ materially from the forecast due to variety of factors. - How to obtain the quarterly financial results briefing materials
The Company is scheduled to hold a teleconference for institutional investors and securities analysts on November 4, 2021. The materials of the teleconference will be posted on the Company's website.
Attachments
- Original document
- Permalink
Disclaimer
KH Neochem Co. Ltd. published this content on 04 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 November 2021 06:31:07 UTC.